Evaluation of the effect of Elaeagnus angustifolia extract on after-pains

Phase 3

• Conditions: after-pains after normal delivery.; Encounter for routine postpartum follow-up; Z39.2

• Registration Number: IRCT20230608058428N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 105

Inclusion Criteria

have the desire to enter the study.
age between 18 to 35 years old.
At least be literate in reading and writing.
The current birth be the second to fourth birth.
Normal delivery, singleton and full term. (Based on the ultrasound of the first trimester or last menstrual valid period)
The baby be alive and healthy.
If there are pains with a score of 4 to 10 based on the pain ruler.
Cephalic presentation.
The baby's weight should be 2500-4000 grams. (weighing recorded in the baby's file)
Not to have any past medical and mental history. (heart disease, chronic Hypertension, and pre-eclampsia, diabetes, kidney and lung disease, autoimmune diseases and all types of neurological and mental diseases)
Not to be allergic to Elaeagnus angustifolia. (Symptoms of allergy include: rhinitis, rhinoconjunctivitis, dermatitis)
Not to be addicted to drugs, psychotropic substances, alcohol or tobacco.
Not to have severe post partum bleeding after delivery.(Bleeding that requires medical measures (other than receiving centocinone) or requiring blood transfer and moving to operating room.)
Not having any history of uterine surgery or caesarean section
Drug analgesia has not been used to reduce labor pain.(Spinal, Epidural, Entonox gas)
Not to have 3 and 4 perineum tears.
The first, second, and third stages of labor should be normal.(First stage: no fast or slow progressing labor, no prolonged rupture of membranes (more than 12 hours), second stage: no instrumental labor, no third and fourth degree rupture, third stage: spontaneous exit of the placenta and membranes)

Exclusion Criteria

Not intend to continue the research
Mother's refusal to take more than one capsule of Elaeagnus angustifolia or placebo
The impossibility of continuing to breastfeed the baby (Due to the death of the baby, hospitalization in NICU)
Any problem that disturbs the routine care of the mother.(Transferring the mother to the operating room-early discharge before 24 hours-hemorrhage or any obstetric problems of the mother that require treatment.)

Study & Design

• Study Type: interventional
• Study Design: Not specified